Gut Liver.  2016 Mar;10(2):162-163. 10.5009/gnl16024.

Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis

Affiliations
  • 1Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. geniushee@yuhs.ac

Abstract

No abstract available.


MeSH Terms

*Adalimumab
Antibodies, Monoclonal, Humanized/therapeutic use
Colitis, Ulcerative/*drug therapy
Humans
Remission Induction
Antibodies, Monoclonal, Humanized
Adalimumab
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr